ArticleJournal of translational medicine2023

Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment.

Tongxuan Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.